Authors:
Sawasaki, T
Shigemasa, K
Shiroyama, Y
Kusuda, T
Fujii, T
Parmley, TH
O'Brien, TJ
Ohama, K
Citation: T. Sawasaki et al., Cyclin E mRNA overexpression in epithelial ovarian cancers: Inverse correlation with p53 protein accumulation, J SOC GYN I, 8(3), 2001, pp. 179-185
Authors:
Shigemasa, K
Shiroyama, Y
Sawasaki, T
Fujii, T
Nagai, N
Parmley, TH
O'Brien, TJ
Ohama, K
Citation: K. Shigemasa et al., Underexpression of cyclin-dependent kinase inhibitor p27 is associated with poor prognosis in serous ovarian carcinomas, INT J ONCOL, 18(5), 2001, pp. 953-958
Authors:
Tanimoto, H
Underwood, LJ
Wang, YX
Shigemasa, K
Parmley, TH
O'Brien, TJ
Citation: H. Tanimoto et al., Ovarian tumor cells express a transmembrane serine protease: A potential candidate for early diagnosis and therapeutic intervention, TUMOR BIOL, 22(2), 2001, pp. 104-114
Authors:
Kawakami, Y
Hama, S
Hiura, M
Nogawa, T
Chiba, T
Yokoyama, T
Takashima, S
Tajiri, H
Eguchi, K
Nagai, N
Shigemasa, K
Ohama, K
Kurisu, K
Heike, Y
Citation: Y. Kawakami et al., Adenovirus-mediated p16 gene transfer changes the sensitivity to taxanes and vinca alkaloids of human ovarian cancer cells, ANTICANC R, 21(4A), 2001, pp. 2537-2545
Authors:
Shigemasa, K
Tanimoto, H
Sakata, K
Nagai, N
Parmley, TH
Ohama, K
O'Brien, TJ
Citation: K. Shigemasa et al., Induction of matrix metalloprotease-7 is common in mucinous ovarian tumorsincluding early stage disease, MED ONCOL, 17(1), 2000, pp. 52-58
Authors:
Shigemasa, K
Underwood, LJ
Beard, J
Tanimoto, H
Ohama, K
Parmley, TH
O'Brien, TJ
Citation: K. Shigemasa et al., Overexpression of testisin, a serine protease expressed by testicular germcells, in epithelial ovarian tumor cells, J SOC GYN I, 7(6), 2000, pp. 358-362
Authors:
Tanimoto, H
Shigemasa, K
Sasaki, M
Katayama, H
Kusumi, I
Parmley, TH
O'Brien, TJ
Ohama, K
Citation: H. Tanimoto et al., Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma, ONCOL REP, 7(6), 2000, pp. 1209-1212
Citation: K. Sakata et al., Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary, INT J ONCOL, 17(4), 2000, pp. 673-681
Authors:
Tanimoto, H
Underwood, LJ
Shigemasa, K
Parmley, TH
Wang, YX
Yan, Y
Clarke, J
O'Brien, TJ
Citation: H. Tanimoto et al., The matrix metalloprotease pump-1 (MMP-7, matrilysin): A candidate marker/target for ovarian cancer detection and treatment, TUMOR BIOL, 20(2), 1999, pp. 88-98
Authors:
Murakami, J
Nagai, N
Shigemasa, K
Ohama, K
Citation: J. Murakami et al., Inhibition of telomerase activity and cell proliferation by a reverse transcriptase inhibitor in gynaecological cancer cell lines, EUR J CANC, 35(6), 1999, pp. 1027-1034
Authors:
Underwood, LJ
Tanimoto, H
Wang, YX
Shigemasa, K
Parmley, TH
O'Brien, TJ
Citation: Lj. Underwood et al., Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma, CANCER RES, 59(17), 1999, pp. 4435-4439
Authors:
Tanimoto, H
Underwood, LJ
Shigemasa, K
Yan, Y
Clarke, J
Parmley, TH
O'Brien, TJ
Citation: H. Tanimoto et al., The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells, CANCER, 86(10), 1999, pp. 2074-2082
Authors:
Oshita, T
Nagai, N
Murakami, J
Sakata, K
Shigemasa, K
Ohama, K
Citation: T. Oshita et al., Expression of human telomerase reverse transcriptase (hTERT) mRNA in endometrial adenocarcinoma, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 121-123
Authors:
Nagai, N
Oshita, T
Murakami, J
Shigemasa, K
Ohama, K
Fujii, T
Katsube, Y
Citation: N. Nagai et al., Clinical evaluation of DNA ploidy and EGFR as a risk factor in gynecologicmalignancies, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 269-271